Search
9MW3011
go.drugbank.com/drugs/DB24999InvestigationalThe drug is an anti-TMPRSS6 (Transmembrane Serine Protease 6, also known as Matriptase-2) monoclonal antibody.[L54591, L54596]
VPM4001
go.drugbank.com/drugs/DB05089ExperimentalInterferon-γ enhances presentation of tumour antigens, whereas interleukin-2 stimulates T cells. … It consists of irradiated human LNCaP cells that have been genetically modified to permanently secrete interferon-γ and interleukin-2 (LNCaP/IL-2/IFN-γ).
Pyruvaldehyde
go.drugbank.com/drugs/DB03587ExperimentalIt has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals. [PubChem]
Isatin
go.drugbank.com/drugs/DB02095ExperimentalThe compound is found in many plants and Schiff bases of Isatin are have been investigated for pharmaceutical applications.
Ammonium molybdate
go.drugbank.com/drugs/DB11128InvestigationalIt is intravenously administered as an additive to solutions for Total Parenteral Nutrition (TPN).
Selisistat
go.drugbank.com/drugs/DB13978InvestigationalEnhances p53 acetylation in response to DNA damaging agents.
SAR443122
go.drugbank.com/drugs/DB16492InvestigationalSAR443122, was investigated in several clinical trials to evaluate its safety and efficacy.
Pimicotinib
go.drugbank.com/drugs/DB18972Investigational[L53748] Pimicotinib was granted Fast Track Designation in December 2023 by the FDA. [L53753]
Lomerizine
go.drugbank.com/drugs/DB14065Experimental[A245383] This drug is used to prophylactically treat migraines[A245368, A245373] and is also being investigated against eye-related diseases that are associated with local circulatory disturbances, an
Reproxalap
go.drugbank.com/drugs/DB16688Investigational[L32990] NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.[L32990]